LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 231

Search options

  1. Article ; Online: Routinematig weefselonderzoek na appendectomie niet nodig.

    van der Valk, Paul

    Nederlands tijdschrift voor geneeskunde

    2022  Volume 166

    Abstract: The article seeks to supply evidence-based data on the usefulness of routine histopathological evaluation of appendectomy specimens taken for non-oncological purposes. Reasons to perform histology are: (1) old-fashioned attitude that everything worth ... ...

    Title translation Routine histopathological evaluation after appendectomy not necessary.
    Abstract The article seeks to supply evidence-based data on the usefulness of routine histopathological evaluation of appendectomy specimens taken for non-oncological purposes. Reasons to perform histology are: (1) old-fashioned attitude that everything worth excising is worthy of histological scrutiny, difficult to maintain in days of cost constraint and ever-improving other techniques to assess such questions; (2) quality assurance of surgical indications; (3) patient safety/security reasons, and (4) lack of other techniques to address diagnostical questions. The authors present a rational evaluation of the pros and cons of histological evaluation, arguing that cost reduction, workload reduction for pathologists and prevention of ineffective follow-up measures will outweigh eventual negative effects. As a pathologist I find the authors present a compelling case. We should try to avoid doing unnecessary work.
    MeSH term(s) Appendectomy/methods ; Humans
    Language Dutch
    Publishing date 2022-08-03
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 82073-8
    ISSN 1876-8784 ; 0028-2162
    ISSN (online) 1876-8784
    ISSN 0028-2162
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Minimaal invasieve obductie.

    van der Valk, Paul

    Nederlands tijdschrift voor geneeskunde

    2020  Volume 164

    Abstract: Today, the postmortem is primarily used to evaluate the quality of the care delivered. It is therefore a cause for concern that over past decades the number of postmortems that have been carried out has been declining. One of the reasons for this is the ... ...

    Title translation Minimally invasive autopsy: the added value of postmortem radiology.
    Abstract Today, the postmortem is primarily used to evaluate the quality of the care delivered. It is therefore a cause for concern that over past decades the number of postmortems that have been carried out has been declining. One of the reasons for this is the increased attention being paid to the physical integrity of the deceased by physicians and next of kin. However, a large number of studies show that 10-25% of post-mortems reveal a discrepancy between the clinical findings and the results of the postmortem. Postmortem radiological investigations make a minimally-invasive postmortem possible. In a number of cases, the diagnostic value of postmortem radiological investigation approaches that of the postmortem. Various studies show that postmortem radiological investigation has additional value, however, it also entails higher costs and logistical problems. The question is to what extent the Dutch healthcare system is prepared to go to implement this new development?
    MeSH term(s) Autopsy/methods ; Autopsy/trends ; Humans ; Netherlands ; Radiography/methods ; Radiography/trends
    Language Dutch
    Publishing date 2020-07-13
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 82073-8
    ISSN 1876-8784 ; 0028-2162
    ISSN (online) 1876-8784
    ISSN 0028-2162
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Specialisatie versus generalisme in de pathologie.

    van der Valk, Paul

    Nederlands tijdschrift voor geneeskunde

    2019  Volume 163

    Abstract: Specialization versus generalization in pathology As medical knowledge increases and deepens, there is a tendency to specialize. This is especially visible in the larger specialties such as internal medicine and surgery, but it also occurs in smaller ... ...

    Title translation Specialization versus generalization in pathology.
    Abstract Specialization versus generalization in pathology As medical knowledge increases and deepens, there is a tendency to specialize. This is especially visible in the larger specialties such as internal medicine and surgery, but it also occurs in smaller fields such as dermatology. The situation is a little different in pathology as there are many more (sub)specializations which causes special problems. Advantages of specialization are, amongst others, increased knowledge and better communication with clinical colleagues. In this paper, the disadvantages - losing sight of the bigger picture, tunnel vision and having problems finding new pathologists who have all the proper qualifications - are weighed against the advantages. Although specialization is probably inevitable, there will still be a need for a generalist, especially when it comes to medical education and filling in when a specialist colleague leaves.
    MeSH term(s) Clinical Competence ; Education, Medical/methods ; Humans ; Pathology, Clinical/education ; Specialization
    Language Dutch
    Publishing date 2019-05-03
    Publishing country Netherlands
    Document type Journal Article ; Review
    ZDB-ID 82073-8
    ISSN 1876-8784 ; 0028-2162
    ISSN (online) 1876-8784
    ISSN 0028-2162
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: ACE2 Protein Expression During Childhood, Adolescence, and Early Adulthood.

    Schurink, Bernadette / Roos, Eva / Vos, Wim / Breur, Marjolein / van der Valk, Paul / Bugiani, Marianna

    Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society

    2022  Volume 25, Issue 4, Page(s) 404–408

    Abstract: Purpose and ... ...

    Abstract Purpose and context
    MeSH term(s) Adolescent ; Adult ; Angiotensin-Converting Enzyme 2 ; COVID-19 ; Endothelial Cells ; Humans ; Peptidyl-Dipeptidase A/metabolism ; SARS Virus/metabolism ; SARS-CoV-2 ; Young Adult
    Chemical Substances Peptidyl-Dipeptidase A (EC 3.4.15.1) ; Angiotensin-Converting Enzyme 2 (EC 3.4.17.23)
    Language English
    Publishing date 2022-02-28
    Publishing country United States
    Document type Journal Article
    ZDB-ID 1463498-3
    ISSN 1615-5742 ; 1093-5266
    ISSN (online) 1615-5742
    ISSN 1093-5266
    DOI 10.1177/10935266221075312
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Evaluation of Exacerbation and Symptom-Free Time in Patients with COPD.

    de Vries, Mirthe I / Effing, Tanja W / van der Palen, Job / Schrijver, Jade / van der Valk, Paul / Lenferink, Anke

    COPD

    2023  Volume 20, Issue 1, Page(s) 9–17

    Abstract: In clinical practice, clinicians mainly focus on Chronic Obstructive Pulmonary Disease (COPD) exacerbations and symptoms, while patients may prefer to evaluate periods free of COPD exacerbations and deteriorated symptoms. The latter would suit the ... ...

    Abstract In clinical practice, clinicians mainly focus on Chronic Obstructive Pulmonary Disease (COPD) exacerbations and symptoms, while patients may prefer to evaluate periods free of COPD exacerbations and deteriorated symptoms. The latter would suit the positive health approach that centralizes people and their beliefs. We aimed to identify patient characteristics and health outcomes relating to: 1) COPD exacerbation-free days; 2) days with no more symptoms than usual; and 3) combined COPD exacerbation and comorbid flare-up-free days (i.e. chronic heart failure, anxiety, depression flare-ups) using negative binomial regression analyzes. Data were obtained from two self-management intervention trials including COPD patients with and without comorbidities. 313 patients (mean age 66.0 years, 63.6% male, 68.7% comorbidity) were included. Better baseline chronic respiratory questionnaire (CRQ) fatigue (incidence rate ratio (IRR) = 1.03 (95% CI 1.01-1.05),
    MeSH term(s) Humans ; Male ; Aged ; Female ; Pulmonary Disease, Chronic Obstructive/diagnosis ; Comorbidity ; Self-Management ; Dyspnea/etiology ; Dyspnea/drug therapy ; Anti-Bacterial Agents/therapeutic use ; Disease Progression ; Quality of Life
    Chemical Substances Anti-Bacterial Agents
    Language English
    Publishing date 2023-08-08
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2171107-0
    ISSN 1541-2563 ; 1541-2555
    ISSN (online) 1541-2563
    ISSN 1541-2555
    DOI 10.1080/15412555.2022.2136066
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Etranacogene dezaparvovec gene therapy for haemophilia B (HOPE-B): 24-month post-hoc efficacy and safety data from a single-arm, multicentre, phase 3 trial.

    Coppens, Michiel / Pipe, Steven W / Miesbach, Wolfgang / Astermark, Jan / Recht, Michael / van der Valk, Paul / Ewenstein, Bruce / Pinachyan, Karen / Galante, Nicholas / Le Quellec, Sandra / Monahan, Paul E / Leebeek, Frank W G

    The Lancet. Haematology

    2024  Volume 11, Issue 4, Page(s) e265–e275

    Abstract: Background: Etranacogene dezaparvovec, the first gene therapy approved for haemophilia B treatment, was shown to be superior to treatment with continuous prophylactic factor IX in terms of bleeding protection 18 months after gene therapy in a phase 3 ... ...

    Abstract Background: Etranacogene dezaparvovec, the first gene therapy approved for haemophilia B treatment, was shown to be superior to treatment with continuous prophylactic factor IX in terms of bleeding protection 18 months after gene therapy in a phase 3 trial. We report post-hoc 24-month efficacy and safety data from this trial to evaluate the longer-term effects of etranacogene dezaparvovec in individuals with haemophilia B.
    Methods: The phase 3 HOPE-B trial enrolled males aged 18 years or older with inherited haemophilia B, classified as severe (plasma factor IX activity level <1%) or moderately severe (plasma factor IX activity level ≥1% and ≤2%), with a severe bleeding phenotype and who were on stable continuous factor IX prophylaxis. Participants were treated with a single infusion of etranacogene dezaparvovec (2 × 10
    Findings: The study began on June 27, 2018, and participants were treated between January, 2019, and March, 2020; the date of data cutoff was April 21, 2022. 54 adult males (40 White, two Asian, one Black or African American, 11 other or missing) received a single intravenous infusion of etranacogene dezaparvovec and were followed for a median of 26·51 months (IQR 24·54-27·99), after a lead-in period of 7·13 months (6·51-7·82). In the updated analysis comparing months 7-24 after gene therapy to the lead-in period, mean adjusted ABR significantly reduced from 4·18 to 1·51 (p=0·0002) for all bleeds and from 3·65 to 0·99 (p=0·0001) for factor IX-treated bleeds. During each 6-month period after gene therapy, at least 67% of participants experienced no bleeding (36 of 54 during months 0-6 and stable thereafter), compared with 14 (26%) of 54 during the lead-in period. 24 months after gene therapy, 1 (2%) participant had one-stage factor IX activity less than 5%, whereas 18 (33%) had factor IX activity more than 40% (non-haemophilia range), with mean factor IX activity stable and sustained at 36·7% (SD 19·0%). 52 (96%) of 54 participants expressed endogenous factor IX, remaining free of factor IX prophylaxis at month 24. No new safety concerns were identified and no treatment-related serious adverse events or treatment-related deaths occurred. The most common treatment-related adverse events were an increase in alanine aminotransferase (nine [17%] of 54 patients), headache (eight [15%]), influenza-like illness (seven [13%]), and an increase in aspartate aminotransferase (five [9%]).
    Interpretation: By providing durable disease correction throughout the 24 months after gene therapy, etranacogene dezaparvovec provides a safe and effective therapeutic option for patients with severe or moderately severe haemophilia B.
    Funding: uniQure and CSL Behring.
    MeSH term(s) Adult ; Male ; Humans ; Hemophilia B/genetics ; Hemophilia B/therapy ; Factor IX/adverse effects ; Factor IX/genetics ; Hemorrhage/prevention & control ; Hemorrhage/chemically induced ; Hemophilia A/drug therapy ; Headache/chemically induced
    Chemical Substances Factor IX (9001-28-9)
    Language English
    Publishing date 2024-03-01
    Publishing country England
    Document type Clinical Trial, Phase III ; Multicenter Study ; Journal Article
    ISSN 2352-3026
    ISSN (online) 2352-3026
    DOI 10.1016/S2352-3026(24)00006-1
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Quality assurance in postgraduate pathology training the Dutch way: regular assessment, monitoring of training programs but no end of training examination.

    van der Valk, Paul

    Virchows Archiv : an international journal of pathology

    2016  Volume 468, Issue 1, Page(s) 109–113

    Abstract: It might seem self-evident that in the transition from a supervised trainee to an independent professional who is no longer supervised, formal assessment of whether the trainee knows his/her trade well enough to function independently is necessary. This ... ...

    Abstract It might seem self-evident that in the transition from a supervised trainee to an independent professional who is no longer supervised, formal assessment of whether the trainee knows his/her trade well enough to function independently is necessary. This would then constitute an end of training examination. Such examinations are practiced in several countries but a rather heterogeneous situation exists in the EU countries. In the Netherlands, the training program is not concluded by a summative examination and reasons behind this situation are discussed. Quality assurance of postgraduate medical training in the Netherlands has been developed along two tracks: (1) not a single testing moment but continuous evaluation of the performance of the trainee in 'real time' situations and (2) monitoring of the quality of the offered training program through regular site-visits. Regular (monthly and/or yearly) evaluations should be part of every self-respecting training program. In the Netherlands, these evaluations are formative only: their intention is to provide the trainee a tool by which he or she can see whether they are on track with their training schedule. In the system in the Netherlands, regular site-visits to training programs constitute a crucial element of quality assurance of postgraduate training. During the site-visit, the position and perceptions of the trainee are key elements. The perception by the trainee of the training program, the institution (or department) offering the training program, and the professionals involved in the training program is explicitly solicited and systematically assessed. With this two-tiered approach high-quality postgraduate training is assured without the need for an end of training examination.
    MeSH term(s) Education, Medical, Graduate/standards ; Humans ; Netherlands ; Pathology, Clinical/education ; Quality Assurance, Health Care/methods ; Quality Assurance, Health Care/standards
    Language English
    Publishing date 2016-01
    Publishing country Germany
    Document type Journal Article
    ZDB-ID 1184867-4
    ISSN 1432-2307 ; 0945-6317
    ISSN (online) 1432-2307
    ISSN 0945-6317
    DOI 10.1007/s00428-015-1895-4
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Neutrophils as a pallbearer for SARS-CoV-2 disease burden - Authors' reply.

    Lutter, René / Schurink, Bernadette / Roos, Eva / Guo, Lihui / van der Valk, Paul / Bugiani, Marianna

    The Lancet. Microbe

    2021  Volume 2, Issue 2, Page(s) e57

    MeSH term(s) Autopsy ; COVID-19 ; Cohort Studies ; Cost of Illness ; Humans ; Neutrophils ; Prospective Studies ; SARS-CoV-2
    Language English
    Publishing date 2021-02-02
    Publishing country England
    Document type Letter ; Comment
    ISSN 2666-5247
    ISSN (online) 2666-5247
    DOI 10.1016/S2666-5247(21)00001-X
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Self-management interventions for people with chronic obstructive pulmonary disease.

    Schrijver, Jade / Lenferink, Anke / Brusse-Keizer, Marjolein / Zwerink, Marlies / van der Valk, Paul Dlpm / van der Palen, Job / Effing, Tanja W

    The Cochrane database of systematic reviews

    2022  Volume 1, Page(s) CD002990

    Abstract: Background: Self-management interventions help people with chronic obstructive pulmonary disease (COPD) to acquire and practise the skills they need to carry out disease-specific medical regimens, guide changes in health behaviour and provide emotional ... ...

    Abstract Background: Self-management interventions help people with chronic obstructive pulmonary disease (COPD) to acquire and practise the skills they need to carry out disease-specific medical regimens, guide changes in health behaviour and provide emotional support to enable them to control their disease. Since the 2014 update of this review, several studies have been published.
    Objectives: Primary objectives To evaluate the effectiveness of COPD self-management interventions compared to usual care in terms of health-related quality of life (HRQoL) and respiratory-related hospital admissions. To evaluate the safety of COPD self-management interventions compared to usual care in terms of respiratory-related mortality and all-cause mortality. Secondary objectives To evaluate the effectiveness of COPD self-management interventions compared to usual care in terms of other health outcomes and healthcare utilisation. To evaluate effective characteristics of COPD self-management interventions.
    Search methods: We searched the Cochrane Airways Trials Register, CENTRAL, MEDLINE, EMBASE, trials registries and the reference lists of included studies up until January 2020.
    Selection criteria: Randomised controlled trials (RCTs) and cluster-randomised trials (CRTs) published since 1995. To be eligible for inclusion, self-management interventions had to include at least two intervention components and include an iterative process between participant and healthcare provider(s) in which goals were formulated and feedback was given on self-management actions by the participant.
    Data collection and analysis: Two review authors independently selected studies for inclusion, assessed trial quality and extracted data. We resolved disagreements by reaching consensus or by involving a third review author. We contacted study authors to obtain additional information and missing outcome data where possible. Primary outcomes were health-related quality of life (HRQoL), number of respiratory-related hospital admissions, respiratory-related mortality, and all-cause mortality. When appropriate, we pooled study results using random-effects modelling meta-analyses.
    Main results: We included 27 studies involving 6008 participants with COPD. The follow-up time ranged from two-and-a-half to 24 months and the content of the interventions was diverse. Participants' mean age ranged from 57 to 74 years, and the proportion of male participants ranged from 33% to 98%. The post-bronchodilator forced expiratory volume in one second (FEV1) to forced vital capacity (FVC) ratio of participants ranged from 33.6% to 57.0%. The FEV1/FVC ratio is a measure used to diagnose COPD and to determine the severity of the disease. Studies were conducted on four different continents (Europe (n = 15), North America (n = 8), Asia (n = 1), and Oceania (n = 4); with one study conducted in both Europe and Oceania). Self-management interventions likely improve HRQoL, as measured by the St. George's Respiratory Questionnaire (SGRQ) total score (lower score represents better HRQoL) with a mean difference (MD) from usual care of -2.86 points (95% confidence interval (CI) -4.87 to -0.85; 14 studies, 2778 participants; low-quality evidence). The pooled MD of -2.86 did not reach the SGRQ minimal clinically important difference (MCID) of four points. Self-management intervention participants were also at a slightly lower risk for at least one respiratory-related hospital admission (odds ratio (OR) 0.75, 95% CI 0.57 to 0.98; 15 studies, 3263 participants; very low-quality evidence). The number needed to treat to prevent one respiratory-related hospital admission over a mean of 9.75 months' follow-up was 15 (95% CI 8 to 399) for participants with high baseline risk and 26 (95% CI 15 to 677) for participants with low baseline risk. No differences were observed in respiratory-related mortality (risk difference (RD) 0.01, 95% CI -0.02 to 0.04; 8 studies, 1572 participants

    low-quality evidence) and all-cause mortality (RD -0.01, 95% CI -0.03 to 0.01; 24 studies, 5719 participants; low-quality evidence). We graded the evidence to be of 'moderate' to 'very low' quality according to GRADE. All studies had a substantial risk of bias, because of lack of blinding of participants and personnel to the interventions, which is inherently impossible in a self-management intervention. In addition, risk of bias was noticeably increased because of insufficient information regarding a) non-protocol interventions, and b) analyses to estimate the effect of adhering to interventions. Consequently, the highest GRADE evidence score that could be obtained by studies was 'moderate'.
    Authors' conclusions: Self-management interventions for people with COPD are associated with improvements in HRQoL, as measured with the SGRQ, and a lower probability of respiratory-related hospital admissions. No excess respiratory-related and all-cause mortality risks were observed, which strengthens the view that COPD self-management interventions are unlikely to cause harm. By using stricter inclusion criteria, we decreased heterogeneity in studies, but also reduced the number of included studies and therefore our capacity to conduct subgroup analyses. Data were therefore still insufficient to reach clear conclusions about effective (intervention) characteristics of COPD self-management interventions. As tailoring of COPD self-management interventions to individuals is desirable, heterogeneity is and will likely remain present in self-management interventions. For future studies, we would urge using only COPD self-management interventions that include iterative interactions between participants and healthcare professionals who are competent using behavioural change techniques (BCTs) to elicit participants' motivation, confidence and competence to positively adapt their health behaviour(s) and develop skills to better manage their disease. In addition, to inform further subgroup and meta-regression analyses and to provide stronger conclusions regarding effective COPD self-management interventions, there is a need for more homogeneity in outcome measures. More attention should be paid to behavioural outcome measures and to providing more detailed, uniform and transparently reported data on self-management intervention components and BCTs. Assessment of outcomes over the long term is also recommended to capture changes in people's behaviour. Finally, information regarding non-protocol interventions as well as analyses to estimate the effect of adhering to interventions should be included to increase the quality of evidence.
    MeSH term(s) Aged ; Hospitalization ; Humans ; Male ; Middle Aged ; Outcome Assessment, Health Care ; Pulmonary Disease, Chronic Obstructive/therapy ; Quality of Life ; Self-Management
    Language English
    Publishing date 2022-01-10
    Publishing country England
    Document type Journal Article ; Review ; Systematic Review
    ISSN 1469-493X
    ISSN (online) 1469-493X
    DOI 10.1002/14651858.CD002990.pub4
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Immunopathology of the optic nerve in multiple sclerosis.

    Fernández Blanco, Laura / Marzin, Manuel / Leistra, Alida / van der Valk, Paul / Nutma, Erik / Amor, Sandra

    Clinical and experimental immunology

    2022  Volume 209, Issue 2, Page(s) 236–246

    Abstract: Optic neuritis, a primary clinical manifestation commonly observed in multiple sclerosis (MS), is a major factor leading to permanent loss of vision. Despite decreased vision (optic neuritis), diplopia, and nystagmus, the immunopathology of the optic ... ...

    Abstract Optic neuritis, a primary clinical manifestation commonly observed in multiple sclerosis (MS), is a major factor leading to permanent loss of vision. Despite decreased vision (optic neuritis), diplopia, and nystagmus, the immunopathology of the optic nerve in MS is unclear. Here, we have characterized the optic nerve pathology in a large cohort of MS cases (n = 154), focusing on the immune responses in a sub-cohort of MS (n = 30) and control (n = 6) cases. Immunohistochemistry was used to characterize the myeloid (HLA-DR, CD68, Iba1, TMEM119, and P2RY12) and adaptive immune cells (CD4, CD8, and CD138) in the parenchyma, perivascular spaces, and meninges in optic nerve tissues from MS and control cases. Of the 154 MS cases, 122 (79%) reported visual problems; of which, 99 (81%) optic nerves showed evidence of damage. Of the 31 cases with no visual disturbances, 19 (61%) showed evidence of pathology. A pattern of myeloid cell activity and demyelination in the optic nerve was similar to white matter lesions in the brain and spinal cord. In the optic nerves, adaptive immune cells were more abundant in the meninges close to active and chronic active lesions, and significantly higher compared with the parenchyma. Similar to brain tissues in this Dutch cohort, B-cell follicles in the meninges were absent. Our study reveals that optic nerve pathology is a frequent event in MS and may occur in the absence of clinical symptoms.
    MeSH term(s) Brain/pathology ; Humans ; Multiple Sclerosis/pathology ; Optic Nerve ; Optic Neuritis/diagnosis ; Optic Neuritis/pathology ; Spinal Cord/pathology
    Language English
    Publishing date 2022-07-03
    Publishing country England
    Document type Journal Article
    ZDB-ID 218531-3
    ISSN 1365-2249 ; 0009-9104 ; 0964-2536
    ISSN (online) 1365-2249
    ISSN 0009-9104 ; 0964-2536
    DOI 10.1093/cei/uxac063
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top